Y. Abramovici

[Acceptability, tolerance and quality of life impact of cyproterone acetate treatment in female hirsutism. Comparison of 2 protocols in combination with oral or transdermal estradiol].

S. Consoli, P. Vexiau, S. Consoli, 1994, Contraception, fertilite, sexualite.

Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia.

A. Yerushalmi, A. Shani, J. Arielly, 1985, The Journal of urology.

Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism

J. Fiet, P. Vexiau, P. Boudou, 2000, Archives of Dermatological Research.

Prolonged refractoriness to the diabetogenic action of streptozotocin in mice.

M. Agarwal, Y. Abramovici, 1985, Biochemical medicine.

Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endothelium-dependent vasodilatation and arterial wall compliance.

M. Dauzat, P. Marés, Y. Abramovici, 2002, Maturitas.

17 beta-Estradiol: oral or parenteral administration in hyperandrogenic women? Metabolic tolerance in association with cyproterone acetate.

J. Fiet, G. Cathelineau, J. Conard, 1995, Fertility and sterility.

[Acne in adult women: data from a national study on the relationship between type of acne and markers of clinical hyperandrogenism].

F. Allaert, P. Vexiau, N. Foin, 2002, Annales de dermatologie et de venereologie.

Control of the proliferation and differentiation of GEJ under platelet aggregating factor treatment.

J. Salamero, J. Remy, J. Charreire, 1987, Acta endocrinologica. Supplementum.